Evaluating Whether Hyperbaric Oxygen Therapy Can Improve VO₂-Max and Reduce Inflammation Markers in Healthy Adults Ages 30-60.

Recruiting

HBOTEvaluating Whether Hyperbaric Oxygen Therapy Can Improve VO₂-Max and Reduce Inflammation Markers in Healthy Adults Ages 30-60.

Sponsor:

University of Texas at Austin

Code:

NCT07361861

Conditions

Cardiovascular Fitness

Inflammation

Eligibility Criteria

Sex: All

Age: 30 - 60

Healthy Volunteers: Accepted

Interventions

Hyperbaric Oxygen Therapy

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-02-05. This information was provided to ClinicalTrials.gov by University of Texas at Austin on 2026-01-23.